US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 12, 2019 (7 years ago)

Hyaluronidase

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Hyaluronidase (PF) Ophthalmic Injection 450 Units/3 mL (150 Units/mL) 3 mL Fill in a 5 mL Single Dose Vial, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678359

Recalling firm
KRS Global Biotechnology, Inc
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0060-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Hyaluronidase recalls

See all
Class II · Moderate risk Terminated

Hylenex recombinant

Reason cGMP Deviations: Temperature excursion

Mckesson Medical-Surgical Inc. Corporate Office NDC 18657-117-04 D-0116-2025
Class II · Moderate risk Terminated

Lidocaine HCL / Bupivacaine HCL

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1548-18 D-0404-2022
Class II · Moderate risk Terminated

LIDOcaine 2%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0071-2020
Class II · Moderate risk Terminated

S-Hyaluronidase 150u/Ml Inj Soln

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0227-2020